我-光束信号在渐进的超核麻中
Sandhya Manorenj1, Shashanka Chillapuram
1Department of Neurology, Princess Esra Hospital, Deccan College of Medical Sciences, Hyderabad, Telangana, India.
Neurology India
|April 3, 2025
概括
在拉力测试中识别的I-beam标志有助于区分渐进性超核性 (PSP) 和异常性帕金森病 (IPD). 患有PSP的患者会刚性地跌倒,与IPD患者不同,IPD患者在跌倒之前可能会采取措施.
科学领域:
- 神经学 神经学
- 运动障碍 运动障碍
背景情况:
- 姿势不稳定是渐进性超核性 (PSP) 和异常性帕金森病 (IPD) 的常见症状.
- 区分这些疾病对于适当的患者管理至关重要.
研究的目的:
- 调查"I-beam标志"在区分IPD与PSP中的实用性.
- 为了强调在拉力测试期间特定姿势反应的诊断价值.
主要方法:
- 进行了向后拉力测试,以评估姿势不稳定性.
- 临床检查包括视线限制的评估和中脑缩的放射性评估.
- 分析了一例65岁的女性,最初明显的姿势不稳定.
主要成果:
- 在患者身上观察到"I-beam标志",其特点是立即下降而没有步骤,类似于没有I-beam的建筑崩.
- 这种迹象表明PSP,与IPD形成鲜明对比,患者通常在跌倒之前采取一个或多个步骤.
- 患者呈现出轻微的向上视线限制和中脑缩,与PSP一致.
结论:
- 在拉力测试期间存在I-beam标志强烈表明帕金森症患者的PSP诊断.
- 这种临床征兆提供了一个有价值的床边工具,用于区分PSP和IPD.
更多相关视频
07:00Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
Published on: October 13, 2016
8.1K
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.7K
相关概念视频
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Prosopagnosia
114
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
114
Parkinson's Disease: Overview
360
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
360
